Lymphangitic carcinomatosis of the lung Is a late and often fatal manifestation of cancer. We describe a case of a biopsy-proved pulmonary lymphangitic carcinomatosis in an asymptomatic 61-year-old man. The pulmonary picture proved to be the initial sign of a prostatic cancer. Therapy with LH-RH analogues and antiandrogens achieved a complete clearance of lung involvement.
Get full access to this article
View all access options for this article.
References
1.
ArandaC., SidhuG., SassoL.A., AdamsF.V.: Transbronchial lung biopsy in the diagnosis of lymphangitic carcinomatosis.Cancer, 42: 1995–1998, 1978.
2.
BatesS.E., TranumB.L.: Perfusion lung scan. An aid in detection of lymphangitic carcinomatosis.Cancer, 50: 232–235, 1982.
3.
BelandG.: Total androgen blockade vs orchiectomy in stage D prostate cancer.In: Prostate cancer. Part A: Research, Endocrin Treatment and Histopathology. Vol. 243A. MurphyG.P., MurphyS., KimR., ChatelainC., and DacisL. (eds.), pp. 391–400, Alan R. Liss, New York, 1987.
4.
BoltonB.M.: Pulmonary metastases from carcinoma of the prostate: a case report of a long remission.J. Urol., 94: 73–77, 1965.
5.
BrickS., HillM.: The mistaken or indeterminate CT diagnosis of hepatic metastases: the value of sonography.A.J.R., 148: 723–726, 1987.
CohenO., LeiboviciL., WysenbeekA.I.: Carcinoma of the prostate as interstitial lung disease.Respiration, 51: 158–160, 1987.
8.
Comura-SchallyA.M., RamalhoA., LeitaoP.R., SchallyA.V.: Clearance of lung metastases of prostate carcinoma after treatment with LH-RH agonist.Lancet, 2: 281–282, 1984.
9.
EmtageL.A., TrenthowanC., HiltonC., ArkellD.G., WallaceD.M.A., HughesM.A., FarrarD.J., YoungC., JonesM., HayA.M., BlacklockA.R.E., RowseA.D., BlackledgeG.R.P.: A randomized trial comparing Zoladex 3.6 mg depot with stilbestrol 3 mg/day in advanced prostate cancer: patient characteristics, response and treatment failures.Eur. J. Cancer Clin. Oncol., 23: 1239, 1987.
10.
FalkowskiW.S., O'ConorV.J.Jr.: Long-term survivor of prostatic carcinoma with lung metastases.J. Urol., 125: 260–262, 1981.
11.
FischeraG., HagerstrandJ.: The small lymph vessels of the lungs in lymphangiosa carcinomatosa.Acta Pathol. Microbiol. Scand., 65: 505–513, 1965.
12.
FraserR.G., PareP.J.A.: Neoplasie metastatiche: In: Diagnosi delle Malattie Toraciche (vol. II), pp. 1247–1265. Casa Editrice Ambrosiana, Milan, 1982.
JanowerM.L., BlennerhassettJ.B.: Lymphangitic spread of metastatic cancer to the lung. A radiologic-pathologic classification.Radiology, 101: 267–273, 1971.
15.
KoutsilierisM., AckmanC.F.: Complete response of lung metastases caused by prostatic cancer after chronic administration of a gonadotropic-releasing hormone analog, buserelin (HOE 766).Prostate, 10: 19–24, 1987.
16.
LindellM.M., DoubledayL.C., von EschenbachA.C., Lib-shitzH.I.: Mediastinal metastases from prostatic carcinoma.J. Urol., 128: 331–334, 1982.
MorinM.E., McNealyG.A., TanA., LiY.P., EngelG., HenneberryM.: Hormonal manipulation of pulmonary metastases from carcinoma of the prostate.Urol. Radiol., 4: 23–27, 1982.
19.
PamiloM., SuramoI., LahdeS.: Comparison of ultrasound and CT images of liver metastases.Acta Radiol., 24: 139–142, 1983.
20.
SchimmelD.H., JulienP.J., GamsuG.: Resolution of pulmonary lymphangitic carcinoma of the breast.Chest, 69: 106–108, 1976.
VolmerM.C., LascanoA., PoggiU.: Lung metastases of prostate carcinoma cleared by intranasal GRM analogue.Lancet, 1: 1507, 1985.
27.
VorobiofD.A., FalksonG.: Nasally administered buserelin inducing complete remission of lung metastases in male breast cancer.Cancer, 59: 688–689, 1987.
28.
YangS.P., LinC.C.: Lymphangitic carcinomatosis of the lungs. The clinical significance of its roentgenologic classification.Chest, 62: 179–187, 1972.
